Report Feature
Biologics Safety Testing Market Trends and Forecast
The future of the global biologics safety testing market looks promising with opportunities in vaccine development and manufacturing, monoclonal antibodies development and manufacturing, cellular & gene therapy product development and manufacturing, and blood and blood product development and manufacturing. The global biologics safety testing market is expected to reach an estimated $8.2 billion by 2028 with a CAGR of 12.8% from 2023 to 2028. The major drivers for this market are increasing pharmaceutical and biotechnology industry, rising concerns over cell culture contamination, and growing R&D investment in life science segment.
A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.
Biologics Safety Testing Market by Segment
The study includes trends and forecast for the global biologics safety testing market by type, product & services, application, and region, as follows:
Biologics Safety Testing Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:
- Endotoxin Test
- Sterility Test
- Mycoplasma Tests
- Bioburden Tests
- Residual Host-cell Proteins & DNA Detection Tests
- Virus safety Test
- Others
Biologics Safety Testing Market by Product & Services [Value ($B) Shipment Analysis from 2017 to 2028]:
- Consumables
- Instrument
- Services
Biologics Safety Testing Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:
- Vaccine Development and Manufacturing
- Monoclonal Antibodies Development and Manufacturing
- Cellular & Gene Therapy Product Development and Manufacturing
- Blood and Blood Product Development and Manufacturing
- Others
Biologics Safety Testing Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Biologics Safety Testing Companies
Companies in the market compete on the basis of type quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, biologics safety testing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduced production costs, and expand their customer base. Some of the biologics safety testing companies profiled in this report includes-
Biologics Safety Testing Market Insights
- Lucintel forecasts that residual host-cell proteins & DNA detection tests are expected to witness the highest growth over the forecast period as it enables the biopharmaceutical manufacturers to demonstrate the safety and purity of their products before the regulatory authorities by testing for residual host cell proteins and DNA.
- Vaccine development and manufacturing is expected to witness the highest growth over the forecast period due to increasing number of infectious diseases and growing necessity of biologics safety testing for quality assurance.
- North America is expected to remain the largest region over the forecast period due to increasing investment in R&D in the biopharmaceutical industry, growing number of biological products and novel drugs, and rising awareness among population towards product safety.
Features of the Biologics Safety Testing Market
- Market Size Estimates: Biologics safety testing market size estimation in terms of value ($B)
- Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Biologics safety testing market size by various segments, such as type, product & services, application, and region
- Regional Analysis: Biologics safety testing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different types, product & services, applications, and regions for the biologics safety testing market.
- Strategic Analysis: This includes M&A, new type development, and competitive landscape for the biologics safety testing market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the biologics safety testing market size?
Answer: The global biologics safety testing market is expected to reach an estimated $8.2 billion by 2028.
Q2. What is the growth forecast for biologics safety testing market?
Answer: The global biologics safety testing market is expected to grow with a CAGR of 12.8% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the biologics safety testing market?
Answer: The major drivers for this market are increasing pharmaceutical and biotechnology industry, rising concerns over cell culture contamination, and growing R&D investment in life science segment.
Q4. What are the major segments for biologics safety testing market?
Answer: The future of the biologics safety testing market looks promising with opportunities in vaccine development and manufacturing, monoclonal antibodies development and manufacturing, cellular & gene therapy product development and manufacturing, and blood and blood product development and manufacturing.
Q5. Who are the key biologics safety testing companies?
Answer: Some of the key biologics safety testing companies is as follows:
Answer: The global biologics safety testing market is expected to reach an estimated $8.2 billion by 2028.
Q2. What is the growth forecast for biologics safety testing market?
Answer: The global biologics safety testing market is expected to grow with a CAGR of 12.8% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the biologics safety testing market?
Answer: The major drivers for this market are increasing pharmaceutical and biotechnology industry, rising concerns over cell culture contamination, and growing R&D investment in life science segment.
Q4. What are the major segments for biologics safety testing market?
Answer: The future of the biologics safety testing market looks promising with opportunities in vaccine development and manufacturing, monoclonal antibodies development and manufacturing, cellular & gene therapy product development and manufacturing, and blood and blood product development and manufacturing.
Q5. Who are the key biologics safety testing companies?
Answer: Some of the key biologics safety testing companies is as follows:
- Charles River Laboratories
- Lonza
- Thermo Fisher Scientific
- Merck KGaA
- F. Hoffmann-La Roche
Q6. Which biologics safety testing segment will be the largest in future?
Answer: Lucintel forecasts that residual host-cell proteins & DNA detection tests are expected to witness the highest growth over the forecast period as it enables the biopharmaceutical manufacturers to demonstrate the safety and purity of their products before the regulatory authorities by testing for residual host cell proteins and DNA.
Q7. In biologics safety testing market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region over the forecast period due to increasing investment in R&D in the biopharmaceutical industry, growing number of biological products and novel drugs, and rising awareness among population towards product safety.
Q8. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.
